The European Patent Office (EPO) has published patent application EP2026030704A1, titled 'Adhesion molecules for targeted infiltration of therapeutic cells.' This publication, dated March 18, 2026, details potential advancements in the field of biotechnology and its application in therapeutic cell infiltration. The application lists several International Patent Classification (IPC) codes related to pharmaceuticals, biotechnology, and molecular biology.

As this is a patent publication, it does not impose direct compliance obligations on regulated entities. However, it is relevant for companies operating in the pharmaceutical and biotechnology sectors, particularly those involved in research and development of cell-based therapies. Companies should monitor patent filings in their areas of interest for potential intellectual property insights and competitive intelligence.